Compare OVID & RWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OVID | RWT |
|---|---|---|
| Founded | 2014 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 562.5M | 597.9M |
| IPO Year | 2017 | 1996 |
| Metric | OVID | RWT |
|---|---|---|
| Price | $2.35 | $3.43 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 9 |
| Target Price | ★ $5.92 | $5.69 |
| AVG Volume (30 Days) | 1.4M | ★ 8.6M |
| Earning Date | 11-11-2026 | 10-28-2026 |
| Dividend Yield | N/A | ★ 20.40% |
| EPS Growth | ★ 3.90 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,252,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $11.84 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 1181.27 | N/A |
| 52 Week Low | $1.18 | $3.22 |
| 52 Week High | $3.11 | $6.97 |
| Indicator | OVID | RWT |
|---|---|---|
| Relative Strength Index (RSI) | 34.43 | 30.92 |
| Support Level | $2.18 | $3.22 |
| Resistance Level | $2.38 | $5.36 |
| Average True Range (ATR) | 0.13 | 0.15 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 6.31 | 0.69 |
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
Redwood Trust Inc is a specialty finance company focused on several distinct areas of housing credit. The company delivers customized housing credit investments to a diverse mix of investors through securitization platforms, whole-loan distribution activities, and its publicly traded securities. The company has four reportable segments: Sequoia Mortgage Banking, CoreVest Mortgage Banking, Redwood Investments, and Legacy Investments. Maximum revenue is generated from the Sequoia Mortgage Banking segment, comprising a mortgage loan conduit that acquires residential consumer loans from third-party originators for subsequent sale to whole loan buyers, securitization through its SEMT private-label securitization program, or transfer into its Redwood Investments portfolio.